Egyptian Essential Drug List 2018-2019

1. ANAESTHETICS; PREOPERATIVE MEDICINES

1.1 General anesthetics and oxygen
1.1.1 Inhalational medicines
1 Halothane Inhalation.(liquid)
2 Isoflurane Inhalation.(liquid)
3 Nitrous oxide Inhalation.(cylinder)
4 Oxygen Inhalation (medicinal gas)
5 Oxygen/helium mixture Inhalation
1.1.2 Injectable medicines
6 Thiopentone Sodium Injection: 0.5 gm;1 gm
7 Ketamine Injection: 50 mg/ml
8 Propofol Injection: 10 mg/ml; 20 mg/ml
1.2 Local anesthetics
Injection: 0.25%; 0.5%
9 Bupivacaine Injection for spinal anesthesia: 0.5% (hydrochloride) in
4 ml ampoule to be mixed with 7.5% glucose solution
Injection: 2%
Gel: 2%
10 Lidocaine Ointment: 5%
Cream: 5%
Oral gel: 2%; 2.5 %
11 Lidocaine + epinephrine (adrenaline) Injection: 2% + 5 mcg/ml
Injection: 30 mg/ml( (For use in spinal anaesthesia during
12 Ephedrine
delivery; to prevent hypotension)
1.3 Preoperative medication and sedation for short-term procedures
13 Atropine Injection: 1 mg/1ml
14 Midazolam Injection: 5 mg/ml
Injection: 10 mg; 20 mg
15 Morphine
Tablet: 30 mg
16 Pethidine Injection: 100 mg/ 2 ml
2.MEDICINES FOR PAIN AND PALLIATIVE CARE
2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)
17 Acetylsalicylic acid Tablet: 300 mg; 500 mg
Injection:75 mg
18 Diclofenac Na
Tablet:50 mg
Tablet: 200 mg; 400 mg
Ibuprofen
19 Suspension:100 mg/5ml
Suppository: 100 mg; 300 mg;500 mg
20 Ketoprofen Injection:100 mg/2 ml
Oral liquid: 120 mg/5 ml
Tablet: 500 mg
Injection: 1 %
21 Paracetamol*
Oral drops: 10 mg/100ml
*Not recommended for anti-inflammatory use due to lack of
proven benefit to that effect).
2.2 Opioid analgesics
22 Codeine Tablet: 30 mg
Injection: 0.05 mg/ml
23 Fentanyl Transdermal patch: 12 mcg/hr; 25 mcg/hr; 50 mcg/hr; 75 mcg/hr;
100 mcg/hr
24 Pethidine Injection: 100 mg/ 2 ml
Injection: 50 mg
25 Tramadol
Tablet: 50 mg
Injection: 10 mg; 20 mg
26 Morphine
Tablet: 30 mg

1
 Egyptian Essential Drug List 2018-2019
Tablet: 5 mg;10 mg
Oral liquid: 5 mg/ 5mL; 10 mg/ 5mL
27 Methadone*
Concentrate for oral liquid: 5 mg/ mL; 10 mg/ mL
*For the management of cancer pain
2.3 Medicines used to treat gout
28 Colchicine Tablet: 0.6 mg
29 Allopurinol Tablet: 100 mg ;300 mg
2.4 Disease modifying agents used in rheumatoid disorders (DMARDs)
30 Azathioprine Tablet: 50 mg
31 Hydroxychloroquine Solid oral dosage form: 200 mg
Tablet:2.5 mg
32 Methotrexate
injection:50 mg
33 Sulfasalazine Tablet: 500 mg
34 Etanercept Injection:25; 50 mg
35 Leflunamide Tablet: 10; 20; 100 mg
2.5 Medicines for other common symptoms in palliative care
36 Amitriptyline Tablet: 10 mg; 25 mg; 75 mg.
Tablet: 50 mg.
37 cyclizine[c]
Injection: 50 mg/ mL.
Tablet: 2 mg[c]; 4 mg.
38 Dexamethasone Injection: 4 mg/ mL.
Oral liquid: 2 mg/5 mL.
Tablet: 5 mg; 10 mg.
Injection: 5 mg/ mL.
39 Diazepam
Oral liquid: 2 mg/5 mL.
Rectal solution: 2.5 mg; 5 mg; 10 mg.
Capsule: 100 mg.
40 Docusate sodium
Oral liquid: 50 mg/5 mL.
Solid oral dosage form: 20 mg
41 Fluoxetine (a)
(a)>8 years
Solid oral dosage form: 0.5 mg; 2 mg; 5 mg.
42 Haloperidol Injection: 5 mg in 1‐ mL ampoule.
Oral liquid: 2 mg/ mL.
43 Hyoscine butylbromide Injection: 20 mg/ mL
Injection: 400 mcg/ mL; 600 mcg/ mL.
44 Hyoscine hydrobromide
Transdermal patches: 1 mg/72 hr.
45 Lactulose Oral liquid: 3.1–3.7 g/5 mL.
46 Loperamide Solid oral dosage form: 2 mg.
Injection: 5 mg/mL in 2‐mL ampoule.
47 Metoclopramide Oral liquid: 5 mg/5 mL.
Solid oral form: 10 mg (hydrochloride).
Solid oral dosage form: 7.5 mg; 15 mg.
48 Midazolam Injection: 1 mg/ mL; 5 mg/ mL.
Oral liquid: 2 mg/ mL[c].
Solid oral dosage form: Eq 4 mg base; Eq 8 mg base.
Injection: 2 mg base/ mL in 2- mL ampoule .
49 Ondansetron[c] (a)
Oral liquid: 4 mg base/5 mL.
(a) >1 month.
50 Senna Oral liquid: 7.5 mg/5 mL.
3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
Tablet: 1 mg; 5 mg:20 mg
51 Prednisolone Syrup: 5 mg/ml[c]
Injection: 250 mg; 500 mg; 1g
Tablet: 4 mg
52 Chlorpheniramine Injection: 5 mg/ml
Syrup: 2 mg/5ml
Tablet: 0.5 mg; 0.75 mg; 8 mg
53 Dexamethasone Injection: 4 mg/ml; 8 mg/ml
Syrup: 2 mg/5ml

2
 Egyptian Essential Drug List 2018-2019
Tablet: 10 mg
54 loratadine
Oral liquid: 1 mg/ mL
55 Epinephrine (adrenaline) Injection: 1 mg/ml
Tablet: 10 mg
56 Hydrocortisone
Injection: 100 mg; 250 mg; 500 mg
57 Betamethasone injection:2 mg/ml
4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONINGS
4.1 Non-specific
58 Charcoal; activated Powder: 25g
4.2 Specific
59 DL Methionine Tablet: 250 mg
Injection: 200 mg/ml
60 Acetylcysteine Oral liquid: 10%[c]; 20% [c]
Sachets:200; 600 mg
61 Atropine Injection: 1 mg/ml
62 Calcium gluconate Injection: 100 mg/ml
63 Hydroxocobalamine Injection:1 mg/ml
64 Naloxone Injection: 400 mcg/1ml
65 Penicillamine Solid oral dosage form: 250 mg
66 Pralidoxime injection:1000 mg/vial
67 Methylthioninium chloride (methylene blue) Injection: 10 mg/ mL
potassium ferric hexacyano-ferrate(II) -2H2O(Prussian
68 Powder for oral administration
blue)
69 fomepizole Injection: 5 mg/ mL; 1 g/ mL
70 Sodium nitrite Injection: 30 mg/ml
71 Sodium thiosulfate Injection: 250 mg/ml
72 Deferoxamine Powder for injection: 500 mg
73 Dimercaprol Injection in oil: 50 mg/ml
74 Sodium calcium edetate Injection: 200 mg/ml
75 Succimer(DMSA) Solid oral dosage form: 100 mg
5. ANTICONVULSANTS/ANTIEPILEPTICS
Syrup: 100 mg/5ml
Tablet : 100 mg; 200 mg; 400 mg
76 Carbamazepine
Oral drops:100 mg/5ml
Supp: 125 mg; 250 mg
Supp: 5 mg
77 Diazepam Tablet: 2 mg; 5 mg
Injection: 10ml
Capsule:100 mg; 300 mg; 400 mg; 600 mg; 800 mg
78 Gabapentin
Solution:250 mg/5ml
Tablet: 25 mg; 50 mg; 100 mg; 200 mg.
Tablet (chewable; dispersible): 2 mg; 5 mg; 25 mg; 50 mg; 100
79 Lamotrigine* mg; 200 mg.
*as adjunctive therapy for treatment-resistant partial or generalized
seizures.
Injection: 2 mg/ml
80 Lorazepam
Tablet: 2 mg
Injection: 500 mg/ml
Injection: 10% in 5ml
81 Magnesium sulfate*
* For use in eclampsia and severe pre-eclampsia and not for other
convulsant disorders
Injection: 200 mg/ml; 40 mg/ml
82 Phenobarbital Oral liquid: 15 mg/5ml
Tablet: 100 mg
Capsule: 50 mg; 100 mg
83 Phenytoin Injection: 250 mg/5ml; 50 mg/ml
Syrup: 30 mg/5ml

3
 Egyptian Essential Drug List 2018-2019

Solution for oromucosal administration: 5 mg/mL; 10 mg/mL

Ampoule: 1 mg/ mL; 10 mg/mL
84 Midazolam*
*for buccal administration when solution for oromucosal
administration is not available

Syrup: 250 mg/5ml

Tablet: 500 mg; 250 mg
85 Valproic acid (sodium valproate)
Injection: 500 mg/5ml
Oral drops: 200 mg/ml
Capsule: 250 mg.
86 Ethosuximide
Oral liquid: 250 mg/5 ml
6. ANTI-INFECTIVE MEDICINES
6.1.1 Intestinal anthelminthics
Tablet: 200 mg
87 Albendazole
Syrup: 20 mg/ml
Tablet: 40 mg
88 Levamisole
Suspension: 40 mg/5ml
Tablet: 100 mg
89 Mebendazole
Suspension: 100 mg/5ml
90 Niclosamide Tablet: 500 mg
Tablet: 600 mg
91 Praziquantel
Syrup: 600 mg/5ml
6.1.2 Antifilarials
Tablet: 200 mg
92 Albendazole
Syrup: 20 mg/ml
93 Diethylcarbamazine Tablet: 50 mg; 100 mg
Tablet : 3 mg; 6 mg
94 Ivermectin lotion: 1%
Suspension: 10 mg/10ml
6.1.3 Antischistosomals and other antitrematode medicines
Tablet: 600 mg
95 Praziquantel
syrup: 600 mg/5ml
96 Triclabendazole Tablet: 250 mg
6.2 Antibacterials
6.2.1 Beta Lactam medicines
Suspenion: 125/5ml; 250/5ml [c]
Capsule: 250 mg; 500 mg; 1g
Powder for injection: 250 mg; 500 mg; 1g
FIRST CHOICE
- community acquired pneumonia (mild to moderate)
- community acquired pneumonia (severe)[c]
- complicated severe acute malnutrition[c]
97 Amoxicillin - exacerbations of COPD
- lower urinary tract infections
- otitis media
- pharyngitis
- sepsis in neonates and children [c]
- sinusitis
- uncomplicated severe acute malnutrition [c]
SECOND CHOICE
- acute bacterial meningitis

4
 Egyptian Essential Drug List 2018-2019
Oral liquid:156 mg/5 ml; 312 mg/5 ml; 228/5ml; 457/5ml; 600
mg/5ml[c]
Tablet: 375 mg; 625 mg; 1gm
Injection: 600 mg; 1.2g

FIRST CHOICE
- community acquired pneumonia (severe)[c]
- complicated intraabdominal infections (mild to moderate)
- exacerbations of COPD
Amoxicillin + clavulanic acid - hospital acquired pneumonia
98
- low-risk febrile neutropenia
- lower urinary tract infections
- sinusitis
- skin and soft tissue infections
SECOND CHOICE
- bone and joint infections
- community-acquired pneumonia (mild to moderate)
- community acquired pneumonia (severe)
- otitis media

Injection: 250 mg; 500 mg; 1g

Tablet: 500 mg; 250 mg
Syrup: 250 mg/5ml ; 125 mg/5ml
FIRST CHOICE
99 Ampicillin - community acquired pneumonia (severe) [c]
- complicated severe acute malnutrition[c]
- sepsis in neonates and children[c]
SECOND CHOICE
- acute bacterial meningitis
Powder for injection: 1.2 million U[c]
100 Benzathine benzylpenicillin FIRST CHOICE
- syphilis
Powder for injection: 0.6 million U;1.2million U
FIRST CHOICE
-community acquired pneumonia (severe) [c]
101 Benzylpenicillin - complicated severe acute malnutrition [c]
- sepsis in neonates and children[c]
- syphili
SECOND CHOICE
- acute bacterial meningitis[c]
Powder for reconstitution with water: 125 mg/5 mL; 250 mg/5 mL
.
Solid oral dosage form: 250 mg.
102 Cefalexin SECOND CHOICE
- exacerbations of COPD
- pharyngitis
- skin and soft tissue infections
Powder for injection: 250 mg; 500 mg; 1 g
(a) >1 month
*also indicated for surgical prophylaxis.

103 Cefazolin* (a)

SECOND CHOICE
- bone and joint infections

5
 Egyptian Essential Drug List 2018-2019
Capsule: 200 mg; 400 mg
Syrup : 100 mg/5ml
104 Cefixime(WATCH GROUP) SECOND CHOICE
- acute invasive bacterial diarrhoea / dysentery
- Neisseria gonorrhoeae
Powder for injection: 250 mg; 500 mg; 1 g
*Do not administer with calcium and avoid in infants with
hyperbilirubinaemia.
(a) >41 weeks corrected gestational age.

FIRST CHOICE
- acute bacterial meningitis
-community acquired pneumonia (severe)
- complicated intraabdominal infections (mild to moderate)
105 Ceftriaxone*(a) (WATCH GROUP) - complicated intrabdominal infections (severe)
- hospital acquired pneumonia
- Neisseria gonorrhoeae
- pyelonephritis or prostatitis (severe)
SECOND CHOICE: -
acute invasive bacterial diarrhoea / dysentery
- bone and joint infections
- pyelonephritis or prostatitis (mild to moderate)
- sepsis in neonates and children [c]

Suspension: 250 mg/5 ml

Tablet: 250 mg
106 Phenoxymethylpenicillin FIRST CHOICE
- community acquired pneumonia (mild to moderate)
- pharyngitis
Injection: 250 mg; 500 mg; 1g
*3rd generation cephalosporin of choice for use in hospitalized
neonates.

FIRST CHOICE
- acute bacterial meningitis
-community acquired pneumonia (severe)
107 Cefotaxime* (WATCH GROUP) - complicated intraabdominal infections (mild to moderate)
- complicated intrabdominal infections (severe)
- hospital acquired pneumonia
-pyelonephritis or prostatitis (severe)
SECOND CHOICE
- bone and joint infections
- pyelonephritis or prostatitis (mild to moderate)
- sepsis in neonates and children [c]

Capsule: 500 mg; 1 g

Powder for injection: 500 mg in vial.
Powder for oral liquid: 125 mg /5 mL.
*used in conjuction with other antibacterials and flucloxacillin
may be used as alternative.

108 Cloxacillin *
FIRST CHOICE
- bone and joint infections
- skin and soft tissue infections
SECOND CHOICE
- sepsis in neonates and children[c]

6
 Egyptian Essential Drug List 2018-2019
Powder for injection: 2 g + 250 mg; 4 g + 500 mg (as sodium salt)
in vial
piperacillin + tazobactam(WATCH GROUP) FIRST CHOICE
109
- complicated intraabdominal infections (severe)
- high-risk febrile neutropenia
- hospital acquired pneumonia
Powder for injection: 500 mg; 1 g in vial
(a) >3 months
SECOND CHOICE
110 meropenem*(a) (WATCH GROUP) - acute bacterial meningitis in neonates [c]
- complicated intraabdominal infections (severe)
- high-risk febrile neutropenia
*imipenem + cilastatin is an alternative except for acute bacterial
meningitis where meropenem is preferred)
111 Ceftazidime (WATCH GROUP) Injection: 250 mg; 500 mg; 1 g
112 Aztreonam (RESERVE GROUP) Powder for injection: 1 g; 2 g in vial
6.2.2 Other antibacterials
Capsule: 150ng; 300 mg
Injection: 150 mg/ml
113 Clindamycin
SECOND CHOICE
- bone and joint infections
Capsule: 250 mg; 500 mg; 1g
114 Cefadroxil Suspension: 125 mg; 250 mg; 500 mg/5ml
Oral drops: 100 mg/ml
Injection: 500 mg in vial.
Oral liquid: 200 mg/5 mL.
Suppository: 500 mg; 1 g.
Tablet: 200 mg to 500 mg.

FIRST CHOICE
115 Metronidazole - C. difficile infection
- complicated intraabdominal infections (mild to moderate)
- complicated intrabdominal infections (severe)
- Trichomonas vaginalis
SECOND CHOICE
- complicated intraabdominal infections (mild to moderate)

Tablet: 500 mg; 350IU

116 Neomycin
Suspenion: 125 mg
117 Cefradine Injection: 1gm
Capsule: 250 mg; 500 mg
Suspension: 125 mg/ 5ml; 250 mg/ 5ml
Injection: 500 mg vial
FIRST CHOICE
-community acquired pneumonia (severe)
SECOND CHOICE
- pharyngitis
*clarithromycin is also listed for use in combination regimens for
118 Clarithromycin* eradication of H. pylori in adults.

7
 Egyptian Essential Drug List 2018-2019
Capsule: 100 mg; 50 mg [c]
(a) Use in children <8 years only for life-threatening infections
when no alternative exists.
FIRST CHOICE
119 Doxycycline(a) - Chlamydia trachomatis
- cholera
SECOND CHOICE
- cholera [c]
- community acquired pneumonia (mild to moderate)
- exacerbations of COPD
Injection: 1g
Capsule: 250 mg; 500 mg
120 Chloramphenicol Suspension: 125 mg/5ml; 250 mg/5ml; 500 mg/5ml
SECOND CHOICE
- acute bacterial meningitis
Injection: 500 mg; 1g
121 Vancomycin (WATCH GROUP) SECOND CHOICE
- C. difficile infection

Suspension: (40 mg/200 mg)/5ml

Tablet: 80 mg/400 mg; 800 mg/160 mg
122 Co-Trimoxazole ( sulphamethoxazole + trimethoprim ) FIRST CHOICE
- lower urinary tract infections
SECOND CHOICE
- acute invasive diarrhoea / bacterial dysentery
Tablet: 250 mg; 500 mg; 750 mg
Injection: 2 mg/ml ( 50ml; 100ml)[c]

FIRST CHOICE
- acute invasive bacterial diarrhoea / dysentery
123 Ciprofloxacin (WATCH GROUP) - low-risk febrile neutropenia
- pyelonephritis or prostatitis (mild to moderate)
SECOND CHOICE
- cholera
- complicated intraabdominal infections (mild to moderate)

Tablet: 50 mg; 100 mg

Suspension: 25 mg/5ml [c]
124 Nitrofurantoin
FIRST CHOICE
- lower urinary tract infections
Injection: 500 mg
125 Levofloxacin
Tablets:250 mg; 500 mg; 750 mg
Tablet:500 mg
126 Erythromycin
Syrup: 250 mg/5ml
Tablet: 250 mg; 500 mg
Syrup: 250 mg
FIRST CHOICE
- Chlamydia trachomatis
127 Azithromycin (WATCH GROUP) - Cholera [c]
- Neisseria gonorrhoeae
SECOND CHOICE
- Acute invasive bacterial diarrhoea / dysentery
- Neisseria gonorrhoeae
Tablet: 500 mg
128 Spiramycin
Syrup: 250 mg/5ml
129 Moxifloxacin Tablet: 500 mg
Tablet: 600 mg
injection: 2 mg/ml
130 linezolide syrup: 100 mg/5ml

8
 Egyptian Essential Drug List 2018-2019
Injection:100 mg; 250 mg; 500 mg
FIRST CHOICE
-pyelonephritis or prostatitis (severe)
131 Amikacin
SECOND CHOICE
- high-risk febrile neutropenia
- sepsis in neonates and children [c]
Injection:20 mg; 40 mg; 80 mg
FIRST CHOICE
- community acquired pneumonia (severe) [c]
132 Gentamicin - complicated severe acute malnutrition [c]
- sepsis in neonates and children [c]
SECOND CHOICE
- Neisseria gonorrhoeae
6.2.3 Antileprosy medicines
133 Clofazimine Capsule: 100 mg
134 Dapsone Tablet :50 mg; 100 mg

Capsule: 150 mg; 300 mg

135 Rifampicin Suspension: 100 mg/5ml; 200 mg/5 ml
Injection: 600 mg

6.2.4 Antituberculosis medicines

136 Pyrazinamide Tablet: 500 mg
137 Ethambutol Tablet: 500 mg
138 Rifampicin + Isoniazid + Pyrazinamide + Ethambutol Tablet: 150 mg + 75 mg + 400 mg + 275 mg
139 Rifampicin + Isoniazid + Pyrazinamide Tablet: 120 mg + 50 mg + 30 mg
140 Isoniazid +B6 Tablet: 100 mg +150 mg
141 Rifampicin + Isoniazid Tablet: 300 mg +150 mg
142 Streptomycin Injection: 1g

Injection for intravenous administration: 2 mg/ mL in 300 mL bag

143 linezolid Powder for oral liquid: 100 mg/5 mL
Tablet: 400 mg; 600 mg

144 Isoniazid Tablet:150 mg

Tablet: 150 mg
145 Rifapentine
*For treatment of latent TB infection (LTBI) only
146 Ethionamide Tablet:500 mg
6.3 Antifungal medicines
Capsule: 50 mg; 150 mg; 200 mg
147 Fluconazole
Injection: 2 mg/ml
Vaginal cream: 1%; 10%.
148 clotrimazole
Vaginal tablet: 100 mg; 500 mg.
Tablet: 125 mg; 500 mg
149 Griseofulvin
Suspension: 125 mg/5ml [c]
Syrup: 100 000 U/ml[c]
150 Nystatin
Tablet: 500 000 U
151 Amphotericin B Injection: 50 mg/15ml
Tablet: 50 mg; 200 mg
Powder for injection: 200 mg in vial
152 Voriconazole* Powder for oral liquid: 40 mg/mL
*For treatment of chronic pulmonary aspergillosis and acute
invasive aspergillosis.
Capsule: 250 mg
153 Flucytosine
Infusion: 2.5g in 250ml

Capsule: 100 mg
154 Itraconazole
Oral liquid: 10 mg/ml

9
 Egyptian Essential Drug List 2018-2019
6.4 Antiviral medicines
6.4.1 Antiherpes medicines
Suspension: 200 mg/5ml [c]; 400 mg/5ml
155 Aciclovir Tablet: 200 mg; 400 mg ;800 mg
Injection : 250 mg; 500 mg; 1 gm
6.4.2 Antiretrovirals
6.4.2.1 Nucleoside/Nucleotide reverse transcriptase inhibitors
Oral liquid: 100 mg/5ml[c]
156 Abacavir (ABC)
Tablet: 300 mg
Oral liquid: 50 mg/5ml[c]
157 Lamivudine (3TC)
Tablet: 150 mg
Capsule:20; 30 mg; 40 mg
158 Stavudine (d4T)
Powder for oral liquid: 5 mg/5ml
159 Tenofovir disoproxil fumarate (TDF) Tablet: 300 mg
Capsule: 100 mg; 250 mg
Zidovudine (ZDV or AZT) Oral liquid: 50 mg/5ml
160
Infusion: 10 mg/ml
Tablet: 300 mg
6.4.2.2 Non-nucleoside reverse transcriptase inhibitors
Oral liquid: 50 mg/5ml
161 Nevirapine (NVP) (a) Tablet: 200 mg
(a)> 6 weeks
Capsule: 50 mg; 100 mg; 200 mg.
162 Efavirenz (EFV or EFZ) (a) Tablet: 200 mg (scored); 600 mg.
(a) >3 years or >10 kg weight.
163 Etravirine Tablet: 100 mg
6.4.2.3 Protease inhibitors
Solid oral dosage form: 150 mg; 200 mg
164 Atazanavir (a)
(a)>25 kg
165 Darunavir Tablet: 75 mg; 400 mg; 600 mg; 800 mg
Oral liquid: 400 mg + 100 mg/5 mL.
166 Lopinavir + Ritonavir (LPV/r)
Tablet (heat stable): 100 mg + 25 mg; 200 mg + 50 mg.
Oral liquid: 400 mg/5 mL.
167 Ritonavir
Tablet (heat stable): 25 mg; 100 mg.
Solid oral dosage form: 200 mg; 500 mg (as mesilate).
168 Saquinavir (SQV)(a)
(a)>25 kg
6.4.2.4 fixed dose combinations
169 Abacavir + Lamivudine Tablet (dispersible; scored): 60 mg (as sulfate) + 30 mg
Tablet: 600 mg + 200 mg + 300 mg (disoproxil fumarate
equivalent to 245 mg tenofovir disoproxil).
170 Efavirenz + Emtricitabine* + Tenofovir *Emtricitabine (FTC) is an acceptable alternative to 3TC; based
on knowledge of the pharmacology; the resistance patterns and
clinical trials of antiretrovirals.
171 Emtricitabine + tenofovir Tablet: 200 mg + 300 mg
Tablet: 150 mg + 200 mg + 30 mg.
172 Lamivudine + Nevirapine + Stavudine
Tablet (dispersible): 30 mg + 50 mg + 6 mg
173 Lamivudine + Nevirapine + Zidovudine Tablet: 30 mg + 50 mg + 60 mg[c]; 150 mg + 200 mg + 300 mg.
174 Lamivudine + Zidovudine Tablet: 150 mg + 300 mg
6.4.2.5 Integrase Inhibitors
175 Dolutegravir Tablet: 50 mg.
Tablet: 100 mg ; 25 mg
176 Raltegravir* *for use in pregnant women and in second-line regimens in
accordance with WHO treatemnt guidelines.
6.4.3 Medicines for hepatitis C
6.4.3.1 Nucleotide polymerase inhibitors
177 sofosbuvir Tablet: 400 mg
6.4.3.2 Protease inhibitors
178 Simeprevir Capsule 150 mg

10
 Egyptian Essential Drug List 2018-2019
6.4.3.3 NS5A inhibitors
179 Daclatasvir Tablet: 30 mg; 60 mg (as hydrochloride)
6.4.3.4 Non-nucleoside polymerase inhibitors
180 Dasabuvir Tablet: 250 mg
6.4.3.5 Other antivirals
Pegylated alpha interferon: 180 micrograms (peginterferon alfa-
2a);
181 Pegylated alpha interferon + ribavirin
80 microgram; 100 microgram (peginterferon alfa-2b).
Ribavirin:200 mg
182 Ledipasvir + Sofosbuvir Tablet: 90 mg + 400 mg.
6.4.4 Antihepatitis B medicines
6.4.4.1 Medicines for hepatitis B - Nucleoside/Nucleotide reverse transcriptase inhibitors
Oral liquid: 0.05 mg/ mL
183 Entecavir
Tablet: 0.5 mg; 1 mg
Tablet: 300 mg (tenofovir disoproxil fumarate – equivalent to 245
184 Tenofovir disoproxil fumarate (TDF)
mg tenofovir disoproxil).
6.4.5 Other antivirals
Capsule: 75 mg.
185 Oseltamivir
Oral powder: 12 mg/ml
186 Valacyclovir Tablet: 500 mg
Tablet: 450 mg .
187 Valganciclovir*
*For the treatment of cytomegalovirus retinitis (CMVr).
188 Ganciclovir Injection
189 Ribavirin Solid oral dosage form: 200 mg; 400 mg; 600 mg
6.5 Antiprotozoal medicines
6.5.1 Antiamoebic and antigiardiasis medicines
Tablet: 500 mg (furoate)
190 Diloxanide (a)
(a) >25 kg
Injection: 5 mg/ml
191 Metronidazole Suspension: 125 mg /5 ml
Tablet: 250 mg; 500 mg
6.5.2 Antileishmaniasis medicines
192 Amphotericin B Powder for injection: 50 mg in vial.
193 Na stibogluconate Injection:100 mg/ml
194 Miltefosine Solid oral dosage form: 10 mg; 50 mg.
Solution for intramuscular injection: 750 mg of paromomycin base
195 Paromomycin
(as the sulfate).
6.5.3 antimalarial
6.5.3.1 For curative treatment
196 Amodiaquine Tablet: 200 mg
Artemether Oily injection: 20 mg/ml; 80 mg/ml
197
Suspension: 300 mg/ml
198 Artemether + lumefantrine Tablet: 20 mg + 120 mg
Tablet: 50 mg; 60 mg
Ampoules : 60 mg
199 Artesunate*
*To be used in combination with either amodiaquine, mefloquine
or sulfadoxine + pyrimethamine.
200 Artesunate + amodiaquine Tablet: (25 mg + 67.5 mg); (50 mg + 135 mg); (100 mg + 270 mg)
Suspension: 80 mg/5 ml
201 Chloroquine Tablet: 250 mg
Injection: 200 mg/5ml
202 Doxycycline Capsule:100 mg
Tablet: 250 mg (as hydrochloride).
203 Mefloquine* (a) (a) >5 kg or (a) >3 months
* To be used in combination with artesunate 50 mg.

Tablet: 500 mg + 25 mg.

204 Sulfadoxine + pyrimethamine*
* Only in combination with artesunate 50 mg.

11
 Egyptian Essential Drug List 2018-2019
205 Quinine Tablet: 300 mg
206 Premaquine Tablet: 15 mg
6.5.3.2 For prophylaxis
Suspension:80 mg/5ml
207 Chloroquine Tablet: 250 mg
Injection: 200 mg/5ml
208 Doxycycline Capsule: 100 mg.
209 Mefloquine Tablet: 250 mg.
6.5.4 Antipneumocystosis and antitoxoplasmosis medicines
210 Pyrimethamine Tablet: 25 mg
211 Sulfadiazine Tablet: 500 mg
Suspension: (40 mg/200 mg)/5ml [c]
212 Sulfamethoxazole + trimethoprim
Tablet: 80 mg + 400 mg[c]; 800 mg + 160 mg
213 Pentamidine Tablet: 200 mg; 300 mg
7. ANTIMIGRAINE MEDICINES
7.1 For treatment of acute attack
214 Acetylsalicylic acid Tablet: 300 mg; 500 mg
Tablet: 200 mg; 400 mg
215 Ibuprofen [c] Suspension:100 mg/5ml
Suppository: 100 mg; 30 mg; 500 mg
Oral liquid: 120 mg/5 ml [c]
Tablet: 500 mg
216 Paracetamol
Injection: 1%
Oral drops: 10 mg/100ml
217 Ergotamine Capsule: 1.5 mg
218 Zolmitryptan Tablet:2.5 mg: 5 mg
7.2 For prophylaxis
Tablet: 10 mg; 40 mg
219 Propranolol
Amp.:1 mg/1ml
8. ANTINEOPLASTIC; IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE
8.1 Immunosuppressive medicines
220 penicillamine Capsule:250 mg
221 Azathioprine Tablet : 50 mg
Capsule: 25 mg; 50 mg; 100 mg
222 Ciclosporin Syrup: 100 mg/ml;50 mg/ml
Injection: 50 mg/1ml
223 Allopurinol Tablet: 100 mg; 300 mg
224 Asparaginase Injection: 10000 IU
225 Bleomycin Powder for injection: 15.000U
Injection: 3 mg/ml; 10 mg/ml; 50 mg/5ml
226 Calcium folinate
Tablet: 15 mg
227 Chlorambucil Tablet: 2 mg
Tablet: 50 mg
228 Cyclophosphamide
Injection: 500 mg;1g
229 Cytarabine Powder for injection: 20 mg/ml; 100 mg/1ml
230 Dacarbazine Powder for injection: 100 mg; 200 mg
231 Dactinomycin Powder for injection: 500 mcg
232 Daunorubicin Powder for injection : 50 mg; 20 mg/4ml
233 Docetaxel Injection: 20 mg/0.5ml; 20 mg/ml; 40 mg/ml
234 Doxorubicin Injection: 2 mg/ml
Injection: 20 mg/ml
235 Etoposide
Capsule : 50 mg
236 Fluorouracil Injection: 25 mg/ml; 50 mg/ml; 100 mg/ml
237 Hydroxycarbamide Solid oral dosage form: 500 mg
238 Thalidomide Capsule:50 mg
239 Bortezomib Injection :3.5 mg
Injection: 50 mg/6ml
240 Fludarabine
Tablet:10 mg
241 Irinotecan Injection: 40 mg/2ml; 100 mg/5ml

12
 Egyptian Essential Drug List 2018-2019
242 Bevacizumab Inection:100 mg/4ml
243 Trastuzumab Injection: 60 mg; 150 mg
244 Rituximab Injection: 500 mg/5ml; 100 mg/10ml
245 Sorafenib Tablet:40 mg
246 Sunitinib Tablet:25 mg
247 Cisplatin Injection: 50 mg/50 mL; 100 mg/100 mL
248 Cetuximab Injection:200 mg/100ml; 100 mg/50ml
249 Carboplatin Injection: 10 mg/ml
250 Oxaloplatin Injection: 50 mg; 100 mg
251 Pemetrexed Injection:100 mg; 500 mg
252 Gemcetabine Injection:200; 1000 mg
253 Capcetabine Tablets:150 mg; 200 mg
254 Epirubicine Injection:2 mg/ml
255 Panitumumab Injection:200 mg/10ml
256 Ifosfamide Injection: 1g; 2g
257 Mercaptopurine Tablet: 50 mg
Injection:100 mg/ml
258 Mesna
Tablet: 400 mg; 500 mg; 600 mg.
Injection: 2.5 mg/ml; 100 mg/ml
259 Methotrexate
Tablet: 2.5 mg
260 Paclitaxel Injection: 6 mg/ml
261 Procarbazine Capsule: 50 mg
262 Thioguanine Solid oral dosage form: 40 mg
263 Vinblastine Injection: 1 mg/ml
264 All-trans retinoid acid (ATRA) Capsule: 10 mg.
265 Vinorelbine Injection: 10 mg/mL in vial; 50 mg/5 mL in vial
266 Nilotinib Capsule: 150 mg; 200 mg.
267 Dasatinib Tablet: 20 mg; 50 mg; 70 mg; 80 mg; 100 mg; 140 mg
268 Bendamustine Injection: 45 mg/0.5 mL; 180 mg/2 mL.
269 Imatinib Tablet: 100 mg; 400 mg.
270 Vincristine Powder for injection: 1 mg/ ml
Concentrate solution for infusion: 4 mg/5 mL in vial.
271 zoledronic acid
Solution for infusion: 4 mg/100 mL in bottle.
8.2 Hormones and antihormones
272 Dexamethasone Tablet: 0.5 mg; 0.75 mg
Injection: 40 mg/ml ;1g ;500 mg
273 Methylprednisolone
Tablet: 4 mg; 8 mg
Oral liquid: 5 mg/ml
274 Prednisolone Tablet: 5 mg; 25 mg
Injection: 25 mg/ml
275 Tamoxifen Tablet: 10 mg ;20 mg
276 hydrocortisone Powder for injection: 100 mg in vial
277 Letrozole Tablet:2.5 mg
278 Anastrazole Tablet:1 mg
279 Exmestane Tablet:25 mg
280 Goserelin Injection: 3.6 mg; 10.8 mg
281 Leuprorolin Injection Depot: 7.5 mg; 11.5 mg; 22.5 mg; 30 mg
282 Bicalutamide Tablet: 50 mg
9.Antiparkinsonism medicines
Tablet: 2 mg
283 Benzatropine Mesylate
Injection: 1 mg/ml
284 Carbidopa + Levodopa Tablet: 10/100; 12.5/50; 25/100; 25/205
Injection: 5 mg/1ml
285 Biperiden
Tablet: 2 mg
10. Medicines affecting the blood
10.1 Antianaemia medicines
Syp: 125 mg/5ml
286 Ferrous salt
Tablet: 200 mg

13
 Egyptian Essential Drug List 2018-2019
Tablet equivalent to 60 mg iron + 400 mcg folic acid
Tablet contains:
287 Ferrous salt + folic acid 250 mcg folic acid + 183 mg ferrous fumarate
300 mcg folic acid + 200 mg ferrous fumarate
350 mcg folic acid + 256.3 mg iron sulphate
288 Iron Injection IM:100 mg
289 Folic acid Tablet: 0.5 mg; 5 mg
Injection: pre-filled syringe 1000IU/ 0.5 mL; 2000IU/ 0.5 mL;
3000IU/ 0.3 mL; 4000IU/ 0.4 mL; 5000IU/ 0.5 mL; 6000IU/ 0.6
mL; 8000IU/ 0.8mL; 10 000IU/ 1 mL; 20 000IU/ 0.5 mL; 40
290 erythropoiesis-stimulating agents* 000IU/ 1 mL
* these agents apply to epoetin alfa; beta and theta; darbepoetin
alfa; methoxy polyethylene glycol-epoetin beta; and their
respective biosimilars.
291 Hydroxocobalamin Injection: 500 mcg; 1 mg/ml
10.2 Medicines affecting coagulation
292 Heparin Sodium Injection: 5000 IU
293 Low molecular weight heparin Prefilled syringe (all available concentrations)
Injection: 1 mg/ml[c]; 10 mg/ml
294 Phytomenadione
Tablet: 10 mg; 5 mg
295 Protamine sulfate Injection: 10 mg/ml
Injection: 100 mg/ml in 10ml ampoule; 100 mg/ml in 5ml
296 Tranexamic acid
Tablet: 500 mg
297 Warfarin Tablet: 1 mg; 2 mg; 3 mg; 5 mg

Injection: 4 micrograms/ mL (as acetate) in 1- mL ampoule. Nasal

298 Desmopressin
spray: 10 micrograms (as acetate) per dose.

Tablet: 250 mg; 500 mg

299 Ethamesylate
Injection: 250 mg/2ml
11. BLOOD PRODUCTS OF HUMAN ORIGIN
11.1 Plasma-derived medicines
11.1.1 Human immunoglobulins
300 Anti-D immunoglobulin Injection: 250 micrograms in single-dose vial.
301 Anti-rabies immunoglobulin Injection: 150 IU/ mL in vial.
302 Anti-tetanus immunoglobulin anti-tetanus immunoglobulin.
11.1.2 Blood coagulation factors
303 Factor VIII concentrate Injection
Factor IX complex (coagulation factors; II; VII; IX;
304 Injection
X) concentrate
12. CARDIOVASCULAR MEDICINES
12.1 Antianginal medicines
305 Isosorbide dinitrate Sublingual tablet: 5 mg; 10 mg
306 Isosorbide mononitrate Tablet: 20 mg; 30 mg: 40 mg; 80 mg; 100 mg
307 Bisoprolol Tablet: 2.5 mg; 5 mg; 10 mg.
Sublingual table: 500 mcg
308 Glyceryl trinitrate Injection: 5 mg/ml; 1 mg/ml
S.R. capsule: 2.5 mg
Tablet: 80 mg; 40 mg; 240 mg
309 Verapamil
Injection: 5 mg/2ml
12.2 Antiarrhythmic medicines
310 Bisoprolol Tablet: 2.5 mg; 5 mg; 10 mg.
Oral liquid: 50 mcg/ml.
311 Digoxin Tablet: 250 mcg
Injection 0.025%
312 Epinephrine (adrenaline) Injection: 1 mg/ml
313 Propafenone Capsules or Tablets: 150 mg
314 Lidocaine Injection: 20%

14
 Egyptian Essential Drug List 2018-2019
Tablet: 80 mg; 40 mg; 240 mg
315 Verapamil
Injection 5 mg/2 ml
Injection: 150 mg
316 Amiodarone
Tablet: 200 mg
12.3 Antihypertensive medicines
317 Lisinopril Tablet: 5 mg; 10 mg; 20 mg
318 Lisinopril + hydrochlorothiazide Tablet: 20 + 12.5 mg
319 Valsartan Tablet: 40 mg; 80 mg; 160 mg; 320 mg
320 Amlodipine Tablet: 5 mg ;10 mg
321 Bisoprolol Tablet: 2.5 mg; 5 mg; 10 mg
322 Captopril(capotril) Tablets or Capsules: 50 mg
323 Sod.nitroprusside Ampoules:50 mg
324 Enalapril Tablet: 5 mg; 10 mg; 20 mg.
325 losartan Tablet: 25 mg; 50 mg; 100 mg
326 Indapamide Tablet: 1.5 mg; 2.5 mg
327 Hydralazine Powder for injection: 20 mg
328 perindopril Tablet:5 mg; 10 mg
329 Hydrochlorothiazide Solid oral dosage form: 12.5 mg; 25 mg
330 Methyldopa Tablet: 250 mg; 500 mg
331 Hydralazine Tablet:10 mg; 25 mg; 50 mg; 100 mg
12.4 Medicines used in heart failure
332 Dobutamine Injection: 250 mg/20ml
333 Bisoprolol Tablet: 2.5 mg; 5 mg; 10 mg
Oral liquid: 50 mcg/ml
334 Digoxin Tablet: 250 mcg
Injection: 0.025%
335 Ivabradine tablet:5 mg: 7.5 mg
336 Lisinopril Tablet: 5 mg; 10 mg; 20 mg
Injection: 10 mg/ml
337 Furosemide
Tablet:20 mg; 40 mg; 500 mg
338 Hydrochlorothiazide Solid oral dosage form: 12.5 mg; 25 mg
339 Dopamine Injection: 40 mg/ml
12.5 Antithrombotic medicines
12.5.1 Anti-platelet medicines
340 acetylsalicylic acid Tablet: 100 mg
341 Clopidogrel Tablet: 75 mg
12.5.2 Thrombolytic medicines
342 streptokinase Powder for injection: 1.5 million IU in vial
12.6 Lipid-lowering agents
343 Atorvastatin Tablet: 10 mg; 20 mg; 80 mg
344 Fenofibrate(micronized) Tablet: 160 mg; 200 mg
12.7 fibrinolytic
345 Streptokinase Vial: 750; 000 I.U.; 1500; 000 I.U
13. DERMATOLOGICAL MEDICINES (topical)
13.1 Antifungal medicines
Powder
346 Econazole
Topical cream: 1%
Cream or ointment: 2%
347 Miconazole Powder: 0.4gm/20g
Lotion: 2%
348 Terbinafine Cream: 1% or Ointment: 1%
13.2 Anti-infective medicines
349 Fusidic acid Ointment or cream: 2%
350 Erythromycin+ zinc acetate Lotion
351 Potassium permanganate Aqueous solution: 1:10 000.
Cream: 1%
352 Silver sulfadiazine (a)
(a)>2 months
353 Mupiracin Cream:2%

15
 Egyptian Essential Drug List 2018-2019
Ointment:0.3%
354 Gentamycin
Cream:.03%
13.3 Anti-inflammatory and antipruritic medicines
Ointment: 0.05%
355 Betamethasone
Cream: 0.1%
356 Calamine Lotion
357 Hydrocortisone Cream or ointment: 1%
13.4 Medicines affecting skin differentiation and proliferation
358 Benzoyl peroxide Gel: 5%; 10%
359 Coal tar Solution: 5%
360 fluorouracil Ointment: 5%.
361 podophyllum resin Solution: 10% to 25%.
362 Salicylic acid Lotion: 6%
363 Urea Cream : 10%
13.5 Scabicides and pediculicides
Lotion: 25%
Gel: 10%
364 Benzyl benzoate (a)
Cream: 10%
(a)> 2 years
Cream or Lotion or Ointment: 2.5%; 5%
365 Permethrin
Shampoo: 1%
14. DIAGNOSTIC AGENTS
14.1 Ophthalmic medicines
366 Tropicamide Eye drops: 0.5%; 1%
367 Fluorescein Eye drops: 1% (sodium salt).
14.2 Radiocontrast media
368 Diatrizoate Meglumine Injection
369 Iodised Oil Injection
370 Iopamidol Injection: 200 mg; 612 mg/ml; 755 mg/ml

Injection: 140 mg to 420 mg iodine (as sodium or meglumine

371 Amidotrizoate
salt)/ml in 20ml ampoule
372 Barium sulfate Oral powder
Injection: 140 mg to 350 mg iodine/ml in 5ml; 10ml; 20ml
373 Iohexol
ampoules.
15. DISINFECTANTS AND ANTISEPTICS
15.1 Antiseptics
374 Povidone Iodine Solution: 7.5%; 10%
Mouth Wash: 125 mg/100ml; 0.1gm/100ml
375 Chlorhexidine
Topical solution: 1%
376 Iodine free antiseptic solution solution
377 Ethanol Solution: 70%
15.2 Disinfectants
378 Chlorine base compound Powder: (0.1% available chlorine) for solution.
379 Chloroxylenol Solution: 4.8%.
380 Glutaral Solution: 2%
381 Alcohol based hand rub Solution containing isopropyl alcohol 75% volume/volume
16. DIURETICS
382 Amiloride + hydrochlorothiazide Tablet: 5 mg +50 mg
Injection: 10 mg/ml ampoule.
383 Furosemide
Tablet: 20 mg[c]; 40 mg; 500 mg.
384 Hydrochlorothiazide Solid oral dosage form: 12.5 mg; 25 mg
385 Mannitol Injectable solution: 10%; 20%
386 Spironolactone Tablet: 25 mg; 50 mg; 100 mg
387 Chlorthalidone Tablet: 25 mg; 50 mg
17. GASTROINTESTINAL MEDICINES

388 Pancreatic enzymes Soild Oral dosage form

16
 Egyptian Essential Drug List 2018-2019
17.1 Antiulcer medicines
Injection: 40 mg
389 Omeprazole
Capsule: 20 mg; 40 mg
Tablet: 150 mg; 300 mg
390 Ranitidine
Injection: 50 mg/5ml; 25 mg/ml
Tablet
391 Aluminium Hydroxide Gel & Magnesium salts or comb.
Suspension
17.2 Antiemetic medicines
Tablet: 0.5 mg; 0.75 mg
392 Dexamethasone Suspension: 2 mg/5ml
Injection: 4 mg/ml
Injection: 10 mg
Tablet: 10 mg
393 Metoclopramide (a) Oral liquid: 5 mg/5 mL [c]
Suppository: 20 mg
(a) Not in neonates
Tablet: 10 mg
394 Domperidone Suspension: 1 mg/1ml
Suppository: 10 mg; 30 mg; 60 mg
Injection: 4 mg/2ml
395 Ondansetron (a) Tablet: 4 mg; 8 mg
(a) >1 month.
17.3 Anti-inflammatory medicines
Retention enema
396 Sulphasalazine Suppository: 500 mg
Tablet: 500 mg
Retention enema
Hydrocortisone Suppository: 25g
397
Tablet: 10 mg
Injection: 100 mg; 250 mg; 500 mg
17.4 Laxatives
Suppository: infant
398 Glycerin
Suppository: Adult
Tablet: 5 mg; 10 mg
399 Bisacodyl
Suppository: 5 mg inf; 10 mg adult
400 Lactulose Syrup: 67gm/100ml
401 Senna Tablet: 7.5 mg; 20 mg
17.5 Medicines used in diarrhoea

Capsule: 200 mg
402 Nifuroxazide
Suspension: 200 mg/5ml

17.5.1 Oral rehydration

Glucose: 75 mEq
Sodium: 75 mEq or mmol/L
Chloride: 65 mEq or mmol/L
Potassium: 20 mEq or mmol/L
Citrate: 10 mmol/L
403 Oral rehydration salts
Osmolarity: 245 mOsm/L
Glucose: 13.5 g/L
Sodium chloride: 2.6 g/L
Potassium chloride: 1.5 g/L
Trisodium citrate dihydrate: 2.9 g/L
17.5.2 Medicines for diarrhoea in children

Solid oral dosage form: 20 mg

404 Zinc sulfate
Powder for oral suspension:10 mg/5ml; 20 mg/5ml

17
 Egyptian Essential Drug List 2018-2019
17.6 Liver diseases
Solid oral dosage form: 140 mg
405 Silymarin containing comp.
Powder for oral suspension: 1gm/100ml
17.7 Antispasmodic
Solid oral dosage form: 100 mg; 200 mg
406 Mebeverine
Suspension: 10 mg/ml
407 Tiemonium methylsulphate 5 mg/2ml Injection
18. HORMONES; OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES
18.1 Adrenal hormones and synthetic substitutes
Tablet: 0.1 mg; 0.2 mg
Sublingual table: 60 mcg; 120 mcg
408 Desmopressin Acetate
Nasal spray: 10 mcg/dose
Injection: 15 mcg/ml; 4 mcg/ml
409 Fludrocortisone Tablet: 0.1 mg
Tablet: 10 mg
410 Hydrocortisone
Injection: 100 mg; 250 mg; 500 mg
18.2 Androgens
Injection: 250 mg/ml
411 Testosterone
Capsule: 40 mg
18.3 Contraceptives
18.3.1 Oral hormonal contraceptives
412 Ethinylestradiol + levonorgestrel Tablet: 35 mcg + 150 mcg
413 Ethinylestradiol + norethisterone Tablet: 30 mcg + 1 mg; 30 mcg + 1.5 mg
18.3.2 Estrogen
414 Estrogen Tablet: 0.625 mg; 1.25 mg; 0.3 mg; 0.45 mg
18.3.3 progesterones
415 Progesterone Supp: 200 mg; 400 mg
18.3.4 Injectable hormonal contraceptives
416 Medroxyprogesterone acetate Injection : 150 mg / 1ml
417 Progesterone acetate Injection : 100 mg / 2ml
18.3.5 Intrauterine devices
418 Copper containing device
Intrauterine system with reservoir containing 52 mg of
419 Levonorgestrel-releasing intrauterine system
levonorestrel
18.3.6 Barrier methods
420 Condoms
421 Diaphragms
18.3.7 Implantable contraceptives
422 Etonogestrel-releasing implant Single-rod etonogestrel-releasing implant
423 levonorgestrel-releasing implant Uni-rod; Two-rod and five-rod levonorgestrel-releasing implant
18.3.8 Intravaginal contraceptives

Progesterone-releasing vaginal ring containing 2.074 g of

424 Progesterone vaginal ring* micronized progesterone.
*For use in women actively breastfeeding at least 4 times per day

18.4 Emergency contraceptive

425 levonorgestrel Tablet: 1.5 mg
18.5 Insulins and other medicines used for diabetes
426 Glibenclamide Tablet: 2.5 mg; 5 mg.
427 Glucagon Injection: 1 mg
428 Insulin injection (soluble) Injection: 100 IU/ml
429 Intermediate acting insulin Injection: 100 IU/ml
430 Insulin mix Injection: 70/30 IU/ml; 50/50 IU/ml
431 Glimpride Tablet: 1 mg; 2 mg; 3 mg; 4 mg
432 Metformin Tablet : 500 mg; 850 mg; 1000 mg

433 Gliclazide Tablet: 60 mg; 30 mg; 80 mg

18
 Egyptian Essential Drug List 2018-2019
18.6 Ovulation inducers
434 Clomifene Tablet: 50 mg
18.7 Thyroid hormones and antithyroid medicines
435 levothyroxine Tablet: 25 mcg[c]; 50 mcg; 100 mcg
436 Carbimazole Tablet: 5 mg
437 Propyl thiouracil Tablet: 50 mg
19. IMMUNOLOGICALS
19.1 Diagnostic agents
438 Tuberculin; purified protein derivative (PPD) Injection
19.2 Sera and immunoglobulins
439 Anti-Scorpion Serum Injection
440 Gas-Gangrene Antitoxin (Polyvalent) Injection
441 Hyperimmunoglobulins Hepatitis HB Injection
442 Anti-D immunoglobulin (human) Injection
443 Antitetanus immunoglobulin (human) Injection
444 Anti snake venom Injection
445 Diphtheria antitoxin Injection
446 Rabies immunoglobulin Injection
19.3 Vaccines
447 Diphtheria + Tetanus Toxoids + Pertussis Vaccine Injection
448 Mumps + Measles + Rubella Virus Vaccine Injection
449 Typhoid + Paratyphoid A&B+ Tetanus Injection
450 Poliomyelitis Vaccine ( inactivated ) Injection
451 BCG vaccine Injection
452 Haemophilus influenzae type b vaccine Injection
453 Hepatitis B vaccine Injection
454 Meningococcal meningitis vaccine Injection
455 Pneumococcal vaccine Injection
456 Poliomyelitis vaccine Oral
457 Rabies vaccine Injection
458 Tetanus vaccine Injection
459 Typhoid vaccine Injection
460 Varicella zoster Injection
461 Rota vaccine Injection
462 Influenza vaccine Injection
463 Yellow fever vaccine Injection
20.1 central Muscle Relaxant
Injection: 30 mg
463 Orphenadrine
Tablet: 100 mg
20.2 Neuromuscular Blockers
464 Atracurium Injection: 10 mg/ml
465 Suxamethonium Injection: 50 mg/ml
466 Vecuronium[c] Injection: 4 mg; 10 mg
20.3 Choline Esterase Inhibitors
Injection: 2.5 mg/ml
467 Neostigmine
Tablet: 15 mg
Tablet: 60 mg
468 Pyridostigmine Tablet S.R: 180 mg
Syrup: 60 mg/5ml
21. OPHTHALMOLOGICAL PREPARATIONS
21.1 Anti-infective agents
Eye drops: 0.5%
469 Chloramphenicol
Eye Ointment: 1%
470 Oxytetracycline+ Polymyxin Eye Ointment
471 Sulfacetamide sodium Eye drops: 15 %; 20 %; 30 %
Eye drops: 0.3%
472 Gentamicin
Eye Ointment: 0.3%
473 Azithromycin Solution (eye drops): 1.5%.

19
 Egyptian Essential Drug List 2018-2019
Ointment: 0.5% [c]
474 Erythromycin* *Infections due to Chlamydia trachomatis or Neisseria
gonorrhoea.
475 Tetracycline Eye ointment: 1%
476 Aciclovir Eye Ointment: 3%
477 Ofloxacin Eye drops: 0.1%; 0.3%
21.2 Anti-inflammatory agents
478 Diclofenac Eye drops: 0.1%
Eye drops: 0.5%; 1%
479 Prednisolone
Eye gel: 0.5%
21.3 Local anaesthetics
480 Benoxinate Eye drops: 0.4%
21.4 Miotics and antiglaucoma medicines
481 Acetazolamide Solid oral dosage form: 250 mg; 500 mg
482 Pilocarpine Injection:
Eye drops:500
1%;mg/5ml
2%; 3%; 4% Eye drop:
Eye drops: 0.25%; 0.5%
483 Timolol
Eye gel: 0.5%
484 Latanoprost Eye drops:0.005%
485 Tropicamide Eye drops:0.5%; 1%
21.5 Mydriatics
Eye ointment : 0.01
486 Atropine (a) Eye drops : 0.01
(a) >3 months.
487 Cyclopentolate Eye drops: 0.5%; 1%
21.6 Anti-vascular endothelial growth factor (VEGF) preparations
488 bevacizumab Injection: 25 mg/ mL.
21.6 other eye drops
489 Naphazoline + Chlorpheniramine Eye drops:0.056% + 0.01%
22. OXYTOCICS AND ANTIOXYTOCICS
22.1 Oxytocics
490 Methyl ergometrine Injection: 200 mcg/1ml
Tablet: 200 micrograms
Vaginal tablet: 25 micrograms.
491 Misoprostol*
*Only for use for induction of labour where appropriate facilities
are available.
492 Oxytocin Injection: 5IU; 10IU
22.2 Antioxytocics (tocolytics)
Tablet: 10 mg
493 Ritodrin
Injection: 10 mg/ml
23. PERITONEAL DIALYSIS SOLUTION
Parenteral solution: calcium
Intraperitoneal dialysis solution (of appropriate
494 chloride+dextrose+sod.chloride+mag.chloride+sod.
composition)
Chloride+sod.acetate+sod.metabis ulfite
24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS
24.1 Medicines used in psychotic disorders
Injection: 25 mg/ml
495 Chlorpromazine[c] Oral liquid: 25 mg/5 ml
Tablet: 25 mg; 100 mg
496 Trifluperazine Tablet : 1 mg; 5 mg
497 Fluphenazine Injection: 25 mg
498 Risperidone Solid oral dosage form: 0.25 mg to 6.0 mg.
499 Clozapine Solid oral dosage form: 25 to 200 mg.
Injection: 5 mg/ml
500 Haloperidol[c] Oral liquid: 2 mg/ml
Solid oral dosage form: 0.5 mg; 1.5 mg; 5 mg; 10 mg

501 Haloperidol decanoate Injection: 50 mg/ml; 100 mg/ml

20
 Egyptian Essential Drug List 2018-2019
24.2 Medicines used in mood disorders
24.2.1 Medicines used in depressive disorders
Tablet: 10 mg; 25 mg; 50 mg
502 Amitriptyline
S.R capsule: 75 mg
Solid oral dosage form: 20 mg
503 Fluoxetine
Delayed release capsule: 90 mg
24.2.2 Medicines used in bipolar disorders
Tablet: 100 mg; 200 mg
S.R. tablet:.200 mg;400 mg
504 Carbamazepine
Syrup: 2%
Rectal Suppository: 125 mg; 250 mg
505 lithium carbonate C.R. tablet: 400 mg
Tablet: 100 mg; 200 mg; 500 mg
Syrup : 200 mg/5ml
506 Valproic acid /sodium valproate
M.r. capsule: 100 mg; 200 mg; 300 mg; 500 mg
Injection: 500 mg/5ml
24.3 Medicines for anxiety disorders
Tablet: 2 mg; 5 mg; 10 mg
Syrup: 2 mg/5ml
507 Diazepam
Suppository: 5 mg; 10 mg
Injection: 5 mg/ml I.v/I.m
508 Bromazepam Tablet: 1.5 mg; 3 mg; 6 mg
24.4 Medicines used for obsessive compulsive disorders
Capsule: 10 mg; 25 mg
509 Clomipramine
S.R. capsule: 75 mg
24.5 Medicines for disorders due to psychoactive substance use
This medicine should only be used within an established support
510 Methadone
programme.
25. MEDICINES ACTING ON THE RESPIRATORY TRACT
25.1 Medicines for chronic obstructive pulmonary disease

511 Beclomethasone Inhalation (aerosol): 50 mcg/ dose; 100 mcg/dose; 250 mcg/dose
512 Budesonide [c] Inhalation powder in capsule + inhaler device: 200 mcg
513 Adrenaline Injection: 1 mg/ml
514 Ipratropium bromide Inhalation (aerosol): 20 mcg/dose
515 Ipratropium bromide+Albuterol sulfate Nebulizer vial: 100 mcg/20 mcg
Tablet: 2.5 mg; 5 mg
516 Terbutaline
Syrup: 0.3 mg/ml
517 salbutamol+ beclomethasone aerosol (200 doses):100 mcg+ 50 mcg
518 Budesonide +formoterol tubular:320 mcg+ 9 mcg
Inhalation (aerosol): 100 mcg/dose; 200 mcg/dose
Tablet: 2 mg; 4 mg; 8 mg
519 Salbutamol
Syrup: 2 mg/5ml
Injection: 0.5 mg/ml; 1 mg/ml
520 Sodium cromoglycate Spinhalar capsule: 20 mg
521 Formetrol Inhalation:12 mcg
522 Fluticasone+Salmetrol Inhalation:50 mcg; 100 mcg; 125 mcg; 250 mcg; 500 mcg

523 Omalizumab Injection:150 mg/1.2ml

25.2 Antihistamines
Tablet: 4 mg
524 Chlorpheniramine Maleate
Syrup: 2 mg/5ml
Tablet: 10 mg
525 Desloratadine
Syrup: 1 mg/ml

Tablet: 4 mg
526 Levocetrizine
Syrup: 0.5 mg/ml

21
 Egyptian Essential Drug List 2018-2019
25.3 Nasal decongestants
Tablet: 60 mg
527 Pseudoephedrine S.R. tablet: 120 mg
Syrup: 10 mg/5ml
528 Pseudo ephedrine + Loratidine Tablet: 120 mg + 5 mg
25.4 Bronchodilators
Injection: 25 mg/ml
529 Aminophylline or other theophylline salts Syrup: 0.116g/5ml
Suppository: 250 mg infantile; 360 mg adult
S.R. tablet: 100 mg; 200 mg; 300 mg; 400 mg
530 Anhydrous theophylline
Syrup: 60 mg/5ml
25.5 Cough Suppressant
Tablet: 10 mg
531 Dextromethorphan Syrup: 7.5 mg/5ml; 10 mg/5ml
Oral drops: 10 mg/ml
25.6 Mucolytics
Capsule:375 mg
532 Carbocysteine
Syrup: 125 mg/5ml; 250 mg/5ml
Tabet: 30 mg
S.R. Capsule: 75 mg
533 Ambroxol Oral Drops: 7.5 mg/ml
Syrup: 15 mg/5ml
injection: 15 mg/2ml
Tablet: 8 mg
534 Bromhexine Elixir: 4 mg/5ml
Oral drops: 30 mg/15ml
25.7 Expectorants
535 Guaiphenesin containing preparation
25.8 immunosupressive Corticosteroid agents
Tablet: 10 mg
536 Hydrocortisone
Injection: 100 mg; 250 mg; 500 mg
Tablet: 5 mg; 25 mg
537 Prednisolone Syrup: 5 mg/5ml
Injection: 25 mg
Injection: 4 mg/ml
538 Dexamethasone Syrup: 2 mg/5ml
Tablet: 0.5 mg; 0.75 mg
Injection: 40 mg/ml
539 Triamcinolone
Tablet: 4 mg
26. SOLUTIONS CORRECTING WATER; ELECTROLYTE AND ACID-BASE
26.1 Oral
Glucose: 75 mEq
Sodium: 75 mEq or mmol/L
Chloride: 65 mEq or mmol/L
Potassium: 20 mEq or mmol/L
Citrate: 10 mmol/L
540 Oral rehydration salts
Osmolarity: 245 mOsm/L
Glucose: 13.5 g/L
Sodium chloride: 2.6 g/L
Potassium chloride: 1.5 g/L
Trisodium citrate dihydrate: 2.9 g/L
Tablet: 600 mg
541 Potassium chloride
Syrup: 6%; 3.3g/100ml
26.2 Parenteral
542 Ringer Lactate Solution Injectable solution
543 Ringer acetate solution Injectable solution
544 Human Albumin Injectable solution: 20%
545 Isoprenaline Injectable solution: 200 mcg/ml

22
 Egyptian Essential Drug List 2018-2019
Injectable solution: 5% (isotonic); 10% (hypertonic);
546 Glucose
25%(hypertonic); 50% (hypertonic)

Injectable solution: 4% glucose; 0.18% sodium chloride

547 Glucose with sodium chloride
Injectable solution: 5% glucose; 0.9% sodium chloride [c]
548 Potassium chloride Injection: 0.15%; 4%; 7.5%[c]; 15% [c]
549 Sodium chloride Injection: 0.45%; 0.9%
550 Sodium bicarbonate Injection: 4.2%; 8.4%
551 Sodium lactate Injection: 1/6 molar
26.3 Miscellaneous
552 Water for injection 2ml; 5ml; 10ml ampoules
27. VITAMINS AND MINERALS
553 Ascorbic acid Tablet: 50 mg.
Injection: 1 mg
554 Vit.B12
Tablet: 1 mg
Tablet
555 Vitamin B containing at least(B1; B6; B12) Syrup
Injection
Tablet: 5 mg; 10 mg
556 Vit. K1 (Phytomenandione)
Injection: 10 mg/ml
557 Vit. D + Calcium Tablet:
558 Calcium carbonate Tablet: 500 mg; 1200 mg
Tablet: 0.25 mcg; 0.5 mcg; 1 mcg
Capsules:0.25 mcg; 0.5 mcg; 1 mcg
559 Alfacalcidole
Injection: 2 mcg/ml
Oral drops: 2 mcg/ml
Oral drops: 2800 I.U./ml
560 Cholecalciferol (Vit. D3)
Injection: 200000 I.U.
Oral solution: 5%
561 Iodine
Oral solutio KI: 10%
Tablet: 50 mcg
562 Vitamin B6 (Pyridoxine)
Injection: in combination
563 Vitamin A Capsule: 25 000 I.U.
564 Vitamin B2 (Riboflavin) Tablet: 5 mg
565 Calcium gluconate Injection: 10%
28. EAR; NOSE AND THROAT CONDITIONS IN CHILDREN
566 Chloramphenicol Ear drops: 5%
567 Ciprofloxacin [c] Topical drops: 0.3%
Nasal spray: 0.1%
568 Xylometazoline (a) Nasal drops: 0.05% [c]; 0.1%
(a) Not in children less than 3 months
569 Budesonide [c] Nasal spray: 32 mcg/dose; 64 mcg
570 Sodium cromoglycate Nasal drops: 2%; 4%
29.Anti-vertigo medicines
571 Cinnarizine Tablets:25 mg; 100 mg
572 Cyclizine Injection:50 mg
573 Betahistine Tablets:8 mg; 16 mg
574 Dimenhydrinate Tablets:50 mg
30. SPECIFIC MEDICINES FOR NEONATAL CARE
30.1 Medicines administered to the neonate

Injection: 20 mg/ml (equivalent to 10 mg caffeine base/ml)

575 Caffeine citrate[c]
Oral liquid: 20 mg/ml (equivalent to 10 mg caffeine base/ml)

576 Chlorhexidine[c] Solution or gel: 7.1%

Solution for injection: 5 mg/ml

577 Ibuprofen (a) oral drops: 5%; 4%
(a)>3 months (except IV form for patent ductus arteriosus)

23
 Egyptian Essential Drug List 2018-2019
578 Surfactant Suspension for intratracheal instillation: 25 mg/ mL or 80 mg/ mL.

Prostaglandin E1: 0.5 mg/ml in alcohol. (ALPROSTADIL)

Prostaglandin E2: 1 mg/ml
Prostaglandin E1(ALPROSTADIL)
579 Prostaglandin E
Injection: 20 mcg
Prostaglandin E2 (DINOPROSTONE)
Inj: 10 mg/ml; 1 mg/0.75 ml; 5 mg/ml

30.2 Medicines administered to the mother

580 Dexamethasone Injection: 4 mg/ mL dexamethasone phosphate (as disodium salt)

31. MEDICINES FOR DISEASES OF JOINTS
31.1 Medicines used to treat gout
581 Allopurinol Tablet: 100 mg.
31.2 Disease-modifying agents used in rheumatoid disorders (DMARDs)
582 Chloroquine Tablet: 100 mg; 150 mg
583 Azathioprine Tablet: 50 mg
584 Hydroxychloroquine Solid oral dosage form: 200 mg
585 Methotrexate Tablet: 2.5 mg
586 Penicillamine Solid oral dosage form: 250 mg
587 Sulfasalazine Tablet: 500 mg
31.3 Juvenile joint diseases
Suppository: 50 mg to 150 mg.
Tablet: 100 mg to 500 mg.
588 Acetylsalicylic acid *(acute or chronic use)
* For use for rheumatic fever; juvenile arthritis; Kawasaki
disease)
32. medicines for Oral Ulcers
589 Triamcinolon Ointement 0.1%; 0.5%
590 Fusafungine Nasal/Oromucosal spray solution1% w/v.
33. medicines for fissures
591 Prednisolone+Lidocaine containing preparation Ointment and Suppository
592 Hydrocortisone+Lidocaine containing preparation Ointment and Suppository
Table 1: Medicines with age or weight restrictions
1 Surfactant Suspension for intratracheal instillation: 25 mg/ml or 80 mg/ml.
2 Atazanavir >25 kg
3 Atropine >3 months
4 Benzyl benzoate >2 years
5 Betamethasone topical preparations Hydrocortisone preferred in neonates
6 Cefazolin >1 month
7 Ceftriaxone >41 weeks corrected gestational age
8 Chlorphenamine >1 year
9 Diloxanide >25 kg
10 Doxycycline >8 years (except for serious infections e.g. cholera)
11 Efavirenz >3 years or >10 kg
12 Emtricitabine >3 months
13 Fluoxetine >8 years
14 Ibuprofen >3 months (except IV form for patent ductus arteriosus)
15 Meropenem >3 months
16 Mefloquine >5 kg or >3 months
17 Metoclopramide Not in neonates
18 Nevirapine (NVP) > 6 weeks
19 Ondansetron >1 month
20 Saquinavir >25 kg
21 Silver sulfadiazine >2 months
22 Tetracaine Not in preterm neonates
23 Trimethoprim >6 months

24
 Egyptian Essential Drug List 2018-2019
24 Xylometazoline >3 months
Term Definition
Refers to tablets or capsules or other solid dosage forms such as
melts
1 Solid oral dosage form That are immediate release preparations. It implies that there is no
difference in clinical efficacy or safety between the available
dosage forms

Refers to:
• Uncoated or coated (film-coated or sugar-coated) tablets that
are intended to be swallowed whole;
2 Tablets
• Unscored and scored;
• Tablets that are intended to be chewed before being swallowed;
• Tablets that are intended to be dispersed

Refers to a specific type of tablet:

Chewable tablets that are intended to be chewed before being
3 Tablets (qualified) swallowed;
Dispersible tablets that are intended to be dispersed in water or
another suitable liquid before being swallowed;

Refers to hard or soft capsules.

4 Capsules The term capsule without qualification is never intended to allow
any type of modified release capsule.
The term capsule with qualification refers to gastro resistant (such
capsules may sometimes be described as enteric coated or as
5 Capsules (qualified)
delayed release); prolonged release or another modified release
form.

Preparations that are issued to patient as granules to be swallowed

Without further preparation; to be chewed; or to be taken in or
6 Granules with water or another suitable liquid.
The term granules without further qualification is never intended
to allow any type

Preparations that are issued to patient as powder (usually as single

7 Oral powder
dose) to be taken in or with water or another suitable liquid.

Liquid preparations intended to be swallowed i.e. oral solutions;

suspensions; emulsions and oral drops; including those
8 Oral liquid constituted from powders or granules; but not those preparations
intended for oromucosal administration e.g. gargles and
mouthwashes.

Refers to solutions; suspensions and emulsions including those

9 Injection
constituted from powders or concentrated solutions.

10 Injection (qualified) Route of administration is indicated in parentheses where relevant.

11 Injection (oily) The term injection is qualified by (oily) in relevant entries.

Refers to solutions and emulsions including those constituted from

12 Intravenous infusion
powders or concentrated solutions.
13 Mode of administration Term to be used
14 To the eye Eye drops; eye ointments.
For liquids: lotions; paints.
15 Topical
For semisolids: cream; ointment.
16 Rectal Suppositories; gel or solution.
17 Vaginal Pessaries or vaginal tablets.
18 Inhalation Powder for inhalation; pressurized inhalation; nebulizer.

25
 Egyptian Essential Drug List 2018-2019

To improve both access and clinical outcomes antibiotics that

were first or second choice antibiotics in at least one of the
19 Group 1 - KEY ACCESS ANTIBIOTICS reviewed syndromes are designated as key ACCESS antibiotics,
emphasizing their role as the antibiotics that should be widely
available, affordable and quality-assured

This group includes antibiotic classes that have higher resistance

potential and so are recommended as first or second choice
20 Group 2 - WATCH GROUP ANTIBIOTICS treatments only for a specific, limited number of indications.
These medicines should be prioritized as key targets of
stewardship programs and monitoring.

This group includes antibiotics that should be treated as “last

resort” options that should be accessible, but whose use should be
tailored to highly specific patients and settings, when all
alternatives have failed (e.g., serious, life-threatening infections
21 Group 3 - RESERVE GROUP ANTIBIOTICS
due to multi-drug resistant bacteria). These medicines could be
protected and prioritized as key targets of national and
international stewardship programs involving monitoring and
utilization reporting, to preserve their effectiveness.

The (a) symbol indicates that there is an age or weight restriction on use of the medicine; details for each medicine can be found
in Table 1
[c] symbol is placed next to an individual medicine or strength of medicine it signifies that there is a specific indication for
restricting its use to children

26
 Egyptian Essential Drug List 2018-2019

Index
A
Abacavir (ABC) 10 Azithromycin 8,19

Abacavir + Lamivudine 10 Aztreonam 7

Acetazolamide 20
B
Acetylcysteine 3 Barium sulfate 16

Acetylsalicylic acid 1,12,15,24 BCG vaccine 19

Aciclovir 10,20 Beclomethasone 21

Adrenaline 3,14,21 Bendamustine 13

Albendazole 4 Benoxinate 20

Alcohol based hand rub 16 Benzathine benzylpenicillin 5

Alfacalcidole 23 Benzatropine Mesylate 13

Allopurinol 2,12,24 Benzoyl peroxide 16

All-trans retinoid acid (ATRA) 13 Benzyl benzoate 16,24

Aluminium Hydroxide Gel 17 Benzylpenicillin 5

Ambroxol 22 Betahistine 23

Amidotrizoate 16 Betamethasone 3,16,24

Amikacin 9 Bevacizumab 13,20

Amiloride + hydrochlorothiazide 16 Bicalutamide 13

Aminophylline 22 Biperiden 13

Amiodarone 15 Bisacodyl 17

Amitriptyline 2,21 Bisoprolol 14,15

Aluminium Hydroxide Gel 17 Bleomycin 12

Ambroxol 22 Bortezomib 12

Amidotrizoate 16 Bromazepam 21

Amikacin 9 Bromhexine 22

Amiloride + hydrochlorothiazide 16 Budesonide 21,,23

Aminophylline 22 Budesonide +formoterol 21

Amiodarone 15 Bupivacaine 1

Amitriptyline 2,21 Bortezomib 12

Amlodipine 15 Bromazepam 21

Amodiaquine 11 Bromhexine 22

Amoxicillin 4
C
Amoxicillin + clavulanic acid 5 Calcium carbonate 23

Amphotericin B 9,11 Calcium folinate 12

Ampicillin 5 Calcium gluconate 3,23

Anastrazole 13 Capcetabine 13

Anhydrous theophylline 22 Captopril(capotril) 15

Anti snake venom 19 Carbamazepine 3,21

Anti-D immunoglobulin 14,19 Carbidopa + Levodopa 13

Anti-rabies immunoglobulin 14 Carbimazole 19

Anti-Scorpion Serum 19 Carbocysteine 22

Anti-tetanus immunoglobulin 14,19 Carboplatin 13

Artemether 11 Cefadroxil 7

Artemether + lumefantrine 11 Cefalexin 5

Artesunate 11 Cefazolin 5,24

Artesunate + amodiaquine 11 Cefixime 6

Ascorbic acid 23 Cefotaxime 6

Asparaginase 12 Cefradine 7

Atazanavir 10 ,24 Ceftazidime 7

Atorvastatin 15 Ceftriaxone 6,24

Atracurium 19 Cetuximab 13

Atropine 1,3,20,24 Charcoal; activated 3

Azathioprine 2,12,24 Chlorambucil 12

27
 Egyptian Essential Drug List 2018-2019
Chloramphenicol 8,19,23 Dimercaprol 3

Chlorhexidine 16,23 Diphtheria + Tetanus Toxoids + Pertussis Vaccine 19

Chlorine base compound 16 Diphtheria antitoxin 19

Chloroquine 11,12,24 DL Methionine 3

Chloroxylenol 16 Dobutamine 15

Chlorpheniramine 2 Docetaxel 12

Chlorpheniramine Maleate 21 Docusate sodium 2

Chlorpromazine 20 Dolutegravir 10

Chlorthalidone 16 Domperidone 17

Cholecalciferol (Vit. D3) 23 Dopamine 15

Ciclosporin 12 Doxorubicin 12

Cinnarizine 23 Doxycycline 8,11,12,24

Ciprofloxacin 8,23
E
Cisplatin 13 Econazole 15

Clarithromycin 7 Efavirenz (EFV or EFZ) 10,24

Clindamycin 7 Efavirenz + Emtricitabine + Tenofovir 10

Clofazimine 9 Emtricitabine + tenofovir 10

Clomifene 19 Enalapril 15

Clomipramine 21 Entecavir 11

Clopidogrel 15 Ephedrine 1

Clotrimazole 9 Epinephrine (adrenaline) 3.14

Cloxacillin 6 Epirubicine 13

Clozapine 20 Ergotamine 12

Coal tar 16 Erythromycin 8,20

Codeine 1 Erythromycin+ zinc acetate 15

Colchicine 2 Erythropoiesis-stimulating agents 14

Condoms 18 Estrogen 18

Copper containing device 18 Etanercept 2

Co-Trimoxazole 8 Ethambutol 9

Cyclizine 2,23 Ethamesylate 14

Cyclopentolate 20 Ethanol 16

Cyclophosphamide 12 Ethinylestradiol + levonorgestrel 18

Cytarabine 12 Ethinylestradiol + norethisterone 18

D Ethionamide 9

Dacarbazine 12 Ethosuximide 4

Daclatasvir 11 Etonogestrel-releasing implant 18

Dactinomycin 12 Etoposide 12

Dapsone 9 Etravirine 10

Darunavir 10 Exmestane 13

Dasabuvir 11
F
Dasatinib 13 Factor IX complex 14

Daunorubicin 12 Factor VIII concentrate 14

Deferoxamine 3 Fenofibrate(micronized( 15

Desloratadine 21 Fentanyl 1

Desmopressin 14 Ferrous salt 13

Desmopressin Acetate 18 Ferrous salt + folic acid 14

Dexamethasone 2,13,17,22,24 Fluconazole 9

Dextromethorphan 22 Flucytosine 9

Diaphragms 18 Fludarabine 12

Diatrizoate Meglumine 16 Fludrocortisone 18

Diazepam 2,3,21 Fluorescein 16

Diclofenac 20 Fluorouracil 12,16

Diclofenac Na 1 Fluoxetine 2,21,24

Diethylcarbamazine 4 Fluphenazine 20

Digoxin 14,15 Fluticasone+Salmetrol 21

Diloxanide 11,24 Folic acid 14

Dimenhydrinate 23 Fomepizole 3

28
 Egyptian Essential Drug List 2018-2019
Formetrol 21 Ipratropium bromide 20

Furosemide 15,16 Ipratropium bromide+Albuterol sulfate 21

Fusafungine 23 Irinotecan 12

Fusidic acid 15 Iron 13

G Isoflurane 1

Gabapentin 3 Isoniazid 9

Ganciclovir 11 Isoniazid +B6 9

Gas-Gangrene Antitoxin 18 Isoprenaline 22

Gemcetabine 12 Isosorbide dinitrate 14

Gentamicin 9,19 Isosorbide mononitrate 14

Glibenclamide 18 Itraconazole 9

Gliclazide 18 Ivabradine 15

Glimpride 18 Ivermectin 4

Glucagon 18
k
Glucose 22 Ketamine 1

Glucose with sodium chloride 22 Ketoprofen 1

Glutaral 16
l
Glycerin 17 Lactulose 2,17

Glyceryl trinitrate 14 Lamivudine (3TC) 10

Goserelin 13 Lamivudine + Nevirapine + Stavudine 10

Griseofulvin 9 Lamivudine + Nevirapine + Zidovudine 10

Guaiphenesin containing preparation 21 Lamivudine + Zidovudine 10

H Lamotrigine 3

Haemophilus influenzae type b vaccine 18 Latanoprost 20

Haloperidol 2,20 Ledipasvir + Sofosbuvir 11

Haloperidol decanoate 20 Leflunamide 2

Halothane 1 Letrozole 13

Heparin Sodium 14 Leuprorolin 13

Hepatitis B vaccine 18 Levamisole 4

Human Albumin 22 Levocetrizine 21

Hydralazine 14,15 Levofloxacin 8

Hydrochlorothiazide 14,15,16 Levonorgestrel 18

Hydrocortisone 3,13,15,17,21 levonorgestrel-releasing implant 18

Hydrocortisone+Lidocaine containing preparation 23 Levonorgestrel-releasing intrauterine system 18

Hydroxocobalamin 3,13 Levothyroxine 19

Hydroxycarbamide 12 Lidocaine 1,14

Hydroxychloroquine 2,23 Lidocaine + epinephrine (adrenaline) 1

Hyoscine butylbromide 2 Linezolid 8,9

Hyoscine hydrobromide 2 Lisinopril 15

Hyperimmunoglobulins Hepatitis HB 18 Lisinopril + hydrochlorothiazide 15

I lithium carbonate 21

Ibuprofen 1,12,23,24 Loperamide 2

IFosfamide 13 Lopinavir + Ritonavir (LPV/r) 10

Imatinib 13 Loratadine 3

Indapamide 15 Lorazepam 3

Influenza vaccine 19 Losartan 15

Insulin injection (soluble) 18 Low molecular weight heparin 14

Insulin mix 18
M
Intermediate acting insulin 18 Magnesium sulfate 3

Intraperitoneal dialysis solution 20 Mannitol 16

Iodine 23 Mebendazole 4

Iodine free antiseptic solution 16 Mebeverine 17

Iodised Oil 16 Medroxyprogesterone acetate 18

Iohexol 16 Mefloquine 11,12.24

Iopamidol 16 Meningococcal meningitis vaccine 19

29
 Egyptian Essential Drug List 2018-2019
Mercaptopurine 13 Pentamidine 12

Meropenem 7.24 Perindopril 15

Mesna 13 Permethrin 16

Metformin 18 Pethidine 1

Methadone 2,21 Phenobarbital 3

Methotrexate 2,13,24 Phenoxymethylpenicillin 6

Methyl ergometrine 20 Phenytoin 3

Methyldopa 15 Phytomenadione 14

Methylprednisolone 13 Pilocarpine 20

Methylthioninium chloride (methylene blue ) 3 piperacillin + tazobactam 7

Metoclopramide 2,17,24 Pneumococcal vaccine 19

Metronidazole 11,7 podophyllum resin 16

Miconazole 15 Poliomyelitis vaccine 19

Midazolam 1,2,4 Poliomyelitis Vaccine ( inactivated( 19

Miltefosine 11 Potassium chloride 22,23

Misoprostol 20 Potassium ferric hexacyano-ferrate(II) -2H2O(Prussian blue) 3

Morphine 1 Potassium permanganate 15

Moxifloxacin 8 Povidone Iodine 16

Mumps + Measles + Rubella Virus Vaccine 19 Pralidoxime 3

Mupiracin 15 Praziquantel 4

N Prednisolone 2,13,20,22

Na stibogluconate 11 Prednisolone+Lidocaine containing preparation 24

Naloxone 3 Premaquine 12

Naphazoline + Chlorpheniramine 20 Procarbazine 13

Neomycin 7 Progesterone 18

Neostigmine 19 Progesterone acetate 18

Nevirapine (NVP) 10,24 Propafenone 14

Niclosamide 4 Propofol 1

Nifuroxazide 17 Propranolol 12

Nilotinib 13 Propyl thiouracil 19

Nitrofurantoin 8 Prostaglandin E 24

Nitrous oxide 1 Protamine sulfate 14

Nystatin 9 Pseudo ephedrine + Loratidine 22

O Pseudoephedrine 22

Ofloxacin 20 Pyrazinamide 9

Omalizumab 21 Pyridostigmine 19

Omeprazole 17 Pyrimethamine 12

Ondansetron 2,17,24
Q
Oral rehydration salts 17,22 Quinine 12

Orphenadrine 19
R
Oseltamivir 11 Rabies immunoglobulin 19

Oxaloplatin 13 Rabies vaccine 19

Oxygen 1 Raltegravir 10

Oxygen/helium mixture 1 Ranitidine 17

Oxytetracycline+ Polymyxin 19 Ribavirin 11

Oxytocin 20 Rifampicin 9

P Rifampicin + Isoniazid 9

Paclitaxel 13 Rifampicin + Isoniazid + Pyrazinamide 9

Pancreatic enzymes 16 Rifampicin + Isoniazid + Pyrazinamide + Ethambutol 9

Panitumumab 13 Rifapentine 9

Paracetamol 1,12 Ringer acetate solution 22

Paromomycin 11 Ringer Lactate Solution 22

Pegylated alpha interferon + ribavirin 11 Risperidone 20

Pemetrexed 13 Ritodrin 20

Penicillamine 3,12,24 Ritonavir 10

30
 Egyptian Essential Drug List 2018-2019
Rituximab 13 Tuberculin; purified protein derivative (PPD) 19

Rota vaccine 19 Typhoid + Paratyphoid A&B+ Tetanus 19

S Typhoid vaccine 19

Salicylic acid 16
U
Saquinavir (SQ) 10.24 Urea 16

Senna 2,17
V
Silver sulfadiazine 15,24 Valacyclovir 11

Silymarin containing comp. 18 Valganciclovir 11

Simeprevir 10 Valproic acid (sodium valproate) 4,21

Sod.nitroprusside 14 Valsartan 15

Sodium bicarbonate 23 Vancomycin 8

Sodium calcium edetate 3 Varicella zoster 19

Sodium chloride 23 Vecuronium 19

Sodium cromoglycate 21,23 Verapamil 14,15

Sodium lactate 23 Vinblastine 13

Sodium nitrite 3 Vincristine 13

Sodium thiosulfate 3 Vinorelbine 13

Sofosbuvir 10 Vit. D + Calcium 23

Sorafenib 13 Vit. K1 (Phytomenandion) 23

Spiramycin 8 Vit.B12 23

Spironolactone 16 Vitamin A 23

Stavudine (d4T) 10 Vitamin B containing at least(B1; B6; B12( 23

Streptokinase 15 Vitamin B2 (Riboflavin) 23

Streptomycin 9 Vitamin B6 (Pyridoxine) 23

Succimer(DMSA) 3 Voriconazole 9

Sulfacetamide sodium 19
W
Sulfadiazine 12 Warfarin 14

Sulfadoxine + pyrimethamine 11 Water for injection 23

Sulfamethoxazole + trimethoprim 12
X
Sulfasalazine 2,24 Xylometazoline 23,25

Sulphasalazine 17
Y
Sunitinib 13 Yellow fever vaccine 19

Surfactant 24
Z
Suxamethonium 19 Zidovudine (ZDV or AZT) 10

T Zinc sulfate 17

Tamoxifen 13 Zoledronic acid 13

Tenofovir disoproxil fumarate (TDF) 10,11 Zolmitryptan 12

Terbinafine 15

Terbutaline 21

Testosterone 18

Tetanus vaccine 19

Tetracycline 20

Thalidomide 12

Thioguanine 13

Thiopentone Sodium 1

Tiemonium methylsulphate 18

Timolol 20

Tramadol 1

Tranexamic acid 14

Trastuzumab 13

Triamcinolone 22,23

Triclabendazole 4

Trifluperazine 20

Tropicamide 16,20

31